Mutual Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $62.8M | Buy |
68,302
+2,493
| +4% | +$2.53M | 1.35% | 9 |
|
|
2025
Q4 | $70.7M | Buy |
65,809
+55
| +0.1% | +$52.6K | 1.52% | 8 |
|
|
2025
Q3 | $54M | Buy |
65,754
+1,963
| +3% | +$1.46M | 1.19% | 10 |
|
|
2025
Q2 | $51.8M | Buy |
63,791
+328
| +0.5% | +$255K | 1.29% | 9 |
|
|
2025
Q1 | $56.1M | Buy |
63,463
+19
| +0% | +$15.8K | 1.61% | 8 |
|
|
2024
Q4 | $48.1M | Buy |
63,444
+1,881
| +3% | +$1.56M | 1.39% | 8 |
|
|
2024
Q3 | $54.9M | Buy |
61,563
+53
| +0.1% | +$47.6K | 1.6% | 7 |
|
|
2024
Q2 | $49.7M | Sell |
61,510
-1,088
| -2% | -$870K | 1.5% | 7 |
|
|
2024
Q1 | $48.7M | Buy |
62,598
+50,197
| +405% | +$35.7M | 1.56% | 7 |
|
|
2023
Q4 | $7.23M | Buy |
12,401
+2,098
| +20% | +$1.22M | 0.25% | 74 |
|
|
2023
Q3 | $5.53M | Sell |
10,303
-2,418
| -19% | -$1.25M | 0.22% | 89 |
|
|
2023
Q2 | $5.97M | Buy |
12,721
+1,801
| +16% | +$755K | 0.23% | 90 |
|
|
2023
Q1 | $3.75M | Buy |
10,920
+1,081
| +11% | +$365K | 0.15% | 138 |
|
|
2022
Q4 | $3.6M | Buy |
9,839
+368
| +4% | +$130K | 0.16% | 133 |
|
|
2022
Q3 | $3.06M | Sell |
9,471
-315
| -3% | -$99.8K | 0.16% | 129 |
|
|
2022
Q2 | $3.17M | Sell |
9,786
-524
| -5% | -$157K | 0.21% | 109 |
|
|
2022
Q1 | $2.95M | Buy |
10,310
+21
| +0.2% | +$5.41K | 0.17% | 145 |
|
|
2021
Q4 | $2.84M | Sell |
10,289
-505
| -5% | -$128K | 0.15% | 164 |
|
|
2021
Q3 | $2.49M | Buy |
10,794
+851
| +9% | +$210K | 0.15% | 174 |
|
|
2021
Q2 | $2.28M | Buy |
9,943
+55
| +0.6% | +$11K | 0.14% | 188 |
|
|
2021
Q1 | $1.85M | Buy |
9,888
+883
| +10% | +$173K | 0.13% | 201 |
|
|
2020
Q4 | $1.52M | Sell |
9,005
-1,155
| -11% | -$172K | 0.11% | 216 |
|
|
2020
Q3 | $1.5M | Sell |
10,160
-203
| -2% | -$31.4K | 0.13% | 180 |
|
|
2020
Q2 | $1.7M | Buy |
10,363
+597
| +6% | +$91.6K | 0.17% | 145 |
|
|
2020
Q1 | $1.35M | Buy |
9,766
+401
| +4% | +$55.1K | 0.18% | 144 |
|
|
2019
Q4 | $1.23M | Buy |
9,365
+279
| +3% | +$32.3K | 0.13% | 190 |
|
|
2019
Q3 | $1.02M | Buy |
9,086
+168
| +2% | +$18.7K | 0.13% | 189 |
|
|
2019
Q2 | $988K | Sell |
8,918
-25
| -0.3% | -$2.94K | 0.13% | 201 |
|
|
2019
Q1 | $1.16M | Sell |
8,943
-152
| -2% | -$18.5K | 0.17% | 143 |
|
|
2018
Q4 | $1.05M | Buy |
9,095
+57
| +0.6% | +$6.37K | 0.21% | 122 |
|
|
2018
Q3 | $970K | Buy |
9,038
+2,438
| +37% | +$244K | 0.15% | 173 |
|
|
2018
Q2 | $563K | Buy |
6,600
+512
| +8% | +$42.1K | 0.13% | 220 |
|
|
2018
Q1 | $471K | Buy |
6,088
+620
| +11% | +$49.9K | 0.12% | 244 |
|
|
2017
Q4 | $462K | Buy |
+5,468
| New | +$465K | 0.17% | 163 |
|
Other funds holding LLY
VCM
VPM
Mutual Advisors's LLY Position: Q1 2026 in Review
Mutual Advisors increased its Eli Lilly (LLY) stake by 3.8% in Q1 2026, buying an estimated $2.53M and bringing the position to 68,302 shares worth $62.8M. The position accounts for 1.35% of the portfolio, ranked #9.
Mutual Advisors first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $70.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Mutual Advisors held 68,302 shares of Eli Lilly worth $62.8M as of Q1 2026.
- Mutual Advisors bought 2,493 Eli Lilly shares in Q1 2026, an estimated $2.53M.
- Eli Lilly made up 1.35% of Mutual Advisors's portfolio in Q1 2026, its #9 holding.
- Mutual Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
- Mutual Advisors's Eli Lilly position peaked at $70.7M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.